Brown Brothers Harriman & Co’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$799K Buy
6,756
+788
+13% +$91K ﹤0.01% 567
2026
Q1
$713K Buy
5,968
+3,658
+158% +$480K ﹤0.01% 507
2025
Q4
$315K Sell
2,310
-385
-14% -$55.4K ﹤0.01% 644
2025
Q3
$398K Buy
2,695
+1,313
+95% +$182K ﹤0.01% 536
2025
Q2
$179K Buy
1,382
+517
+60% +$62.6K ﹤0.01% 657
2025
Q1
$103K Sell
865
-38
-4% -$4.71K ﹤0.01% 696
2024
Q4
$105K Sell
903
-70
-7% -$8.85K ﹤0.01% 709
2024
Q3
$131K Buy
973
+108
+12% +$14.4K ﹤0.01% 646
2024
Q2
$117K Hold
865
﹤0.01% 634
2024
Q1
$112K Hold
865
﹤0.01% 629
2023
Q4
$98.9K Sell
865
-38
-4% -$3.79K ﹤0.01% 620
2023
Q3
$82.2K Buy
903
+38
+4% +$3.92K ﹤0.01% 635
2023
Q2
$97.4K Hold
865
﹤0.01% 602
2023
Q1
$90.6K Sell
865
-200
-19% -$20.9K ﹤0.01% 632
2022
Q4
$118K Sell
1,065
-45
-4% -$4.72K ﹤0.01% 567
2022
Q3
$97K Sell
1,110
-26
-2% -$2.36K ﹤0.01% 598
2022
Q2
$89K Buy
1,136
+42
+4% +$3.47K ﹤0.01% 603
2022
Q1
$93K Sell
1,094
-16
-1% -$1.53K ﹤0.01% 648
2021
Q4
$133K Sell
1,110
-3,431
-76% -$426K ﹤0.01% 549
2021
Q3
$562K Buy
4,541
+3,643
+406% +$469K ﹤0.01% 305
2021
Q2
$108K Buy
898
+3
+0.3% +$343 ﹤0.01% 542
2021
Q1
$94K Sell
895
-40
-4% -$4.06K ﹤0.01% 532
2020
Q4
$95K Buy
935
+4
+0.4% +$376 ﹤0.01% 564
2020
Q3
$78K Buy
931
+614
+194% +$47.8K ﹤0.01% 520
2020
Q2
$21K Buy
317
+251
+380% +$16.6K ﹤0.01% 684
2020
Q1
$4K Buy
66
+16
+32% +$1.26K ﹤0.01% 846
2019
Q4
$4K Sell
50
-134
-73% -$10.4K ﹤0.01% 1002
2019
Q3
$15K Sell
184
-2,475
-93% -$194K ﹤0.01% 842
2019
Q2
$222K Sell
2,659
-951
-26% -$75.8K ﹤0.01% 380
2019
Q1
$285K Buy
3,610
+510
+16% +$37.2K ﹤0.01% 334
2018
Q4
$207K Buy
3,100
+300
+11% +$20.8K ﹤0.01% 340
2018
Q3
$224K Sell
2,800
-2,725
-49% -$203K ﹤0.01% 352
2018
Q2
$372K Buy
+5,525
New +$401K ﹤0.01% 261
2018
Q1
Sell
-10,435
Closed -$712K 1153
2017
Q4
$712K Buy
10,435
+8,590
+466% +$570K ﹤0.01% 216
2017
Q3
$116K Buy
1,845
+1,020
+124% +$61K ﹤0.01% 392
2017
Q2
$46K Hold
825
﹤0.01% 491
2017
Q1
$41K Buy
+825
New +$40.2K ﹤0.01% 514
2015
Q1
Sell
-278
Closed -$11K 866
2014
Q4
$11K Hold
278
﹤0.01% 691
2014
Q3
$10K Hold
278
﹤0.01% 671
2014
Q2
$11K Hold
278
﹤0.01% 652
2014
Q1
$10K Sell
278
-278
-50% -$10.1K ﹤0.01% 669
2013
Q4
$20K Buy
556
+278
+100% +$8.94K ﹤0.01% 592
2013
Q3
$8K Hold
278
﹤0.01% 597
2013
Q2
$7K Buy
+278
New +$7.68K ﹤0.01% 667

Other funds holding XYL

Brown Brothers Harriman & Co's XYL Position: Q2 2026 in Review

Brown Brothers Harriman & Co increased its Xylem (XYL) stake by 13% in Q2 2026, buying an estimated $91K and bringing the position to 6,756 shares worth $799K. The position accounts for ﹤0.01% of the portfolio, ranked #567.

Brown Brothers Harriman & Co first reported a position in XYL in Q2 2013 and has held it in 44 quarters since. 1,093 funds tracked by Wall St. Rank hold XYL as of Q2 2026.

  • Brown Brothers Harriman & Co held 6,756 shares of Xylem worth $799K as of Q2 2026.
  • Brown Brothers Harriman & Co bought 788 Xylem shares in Q2 2026, an estimated $91K.
  • Xylem made up ﹤0.01% of Brown Brothers Harriman & Co's portfolio in Q2 2026, its #567 holding.
  • Brown Brothers Harriman & Co first reported a position in Xylem in Q2 2013 and has held it in 44 quarters since.
  • 1,093 funds tracked by Wall St. Rank held Xylem as of Q2 2026.

Based on Brown Brothers Harriman & Co's 13F filing for Q2 2026, filed 12 Aug 2026.